TERIFLUNOMIDE
Generic: TERIFLUNOMIDE
MSN LABORATORIES PRIVATE LIMITEDManufacturer
ORALRoute
TERIFLUNOMIDEActive Substance
2019-04-24Original Approval
TERIFLUNOMIDE is FDA application ANDA209623, sponsored by MSN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
FATIGUE
840 reports
2
ALOPECIA
832 reports
3
DIARRHOEA
774 reports
4
MULTIPLE SCLEROSIS RELAPSE
653 reports
5
HYPOAESTHESIA
608 reports
6
FALL
570 reports
7
HEADACHE
555 reports
8
CONDITION AGGRAVATED
544 reports
9
PARAESTHESIA
516 reports
10
GAIT DISTURBANCE
514 reports